469.37
Past performance is not a reliable indicator of future results
What is Vertex (VRTX)?
Vertex Pharmaceuticals Incorporated is a biotechnology company focused on the development and commercialization of therapies for serious diseases, particularly in the area of cystic fibrosis. The company engages in research and development of small molecule drugs and gene-editing technologies aimed at treating genetic disorders. Vertex's portfolio includes treatments that target the underlying causes of diseases rather than just symptoms. The company invests in innovation across multiple therapeutic areas, including rare diseases and other serious conditions. Vertex collaborates with academic institutions, research organizations, and industry partners to advance its pipeline. Its operations encompass drug discovery, clinical development, regulatory affairs, and manufacturing. Vertex is recognized for its contributions to precision medicine and its focus on transformative therapies.
Vertex Stock Price Today: Live Overview
The price today is shaped by the session’s activity with Vertex currently at $469.37. It has recorded a low of $468.07 and a high of $485.02, showing a daily change of 0%.
FAQ: Vertex (VRTX)
What is the current price of VRTX stock?
The current price stands at $469.37.
Does VRTX pay dividends?
Vertex pays dividends via cash distributions (if applicable).
Does VRTX have a formal corporate presence or regional headquarters in the UAE?
Vertex does not have a direct presence in the UAE and operates via partners.
What is VRTX best known for?
The company is most famous for its treatments for cystic fibrosis and other serious diseases.
What assets are typically shown together with VRTX?
Commonly shown alongside VRTX: Tarsus Pharmaceuticals, Inc., JPMorgan Active Growth ETF, Royalty Pharma plc
Latest shares articles
Ratings and Reviews
Ratings and Reviews
